Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2006-04-04
2006-04-04
Foley, Shanon (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C424S199100, C435S235100, C435S236000, C536S023720, C536S024100
Reexamination Certificate
active
07022327
ABSTRACT:
The present invention provides a birnavirus mutant which is suited as vaccine candidate in eradication control programmes. The mutant is not able to produce a native VP5 protein, and this feature can be used as a marker to distinguish between animals vaccinated with the VP5 mutant or infected with a naturally-occurring birnavirus.
REFERENCES:
patent: 5279965 (1994-01-01), Keeler
patent: 5328688 (1994-07-01), Roizman
patent: 5690937 (1997-11-01), Parkin et al.
patent: 5993824 (1999-11-01), Murphy et al.
patent: 91/02795 (1991-03-01), None
patent: WO 95/26196 (1995-10-01), None
Heppell et al. Journal of General virology 76: 2091-2096, 1995.
Mundt, E. Bundesforchungsanstalt fur Viruskrankheiten de Tiere; Jahresbericht 1996, p. 51, published Apr. 16, 1997 (with English translation).
Lewin, B. Genes IV, p. 70-73, Oxford University Press, 1990.
Culver et al. Virology 173:755-758, 1989.
Kibenge et al. 1988. Growth of serotypes I and II and variant strains of infectious bursal disease virus in Vero cells. Avian Diseases vol. 32 (2): p. 298-303, (abstract only cited).
Murphy et al. Journal of Leukocyte Biology. 1994; 56 (3): 294-303, abstract only.
Fernholz et al. Virology. 1993; 197 (1): 64-73, abstract only.
E. Mundt et al.,Proc. Natl. Acad. Sci. USA, 93:11131-11136, 1996.
E. Mundt et al.,Journal of General Virology, 76:437-443, 1995.
E. Mundt et al.,Journal of Virology, 71:7:5647-5651, 1997.
Yao et al., “Generation of a Mutant Infectious Bursal Disease Virus That Does Not Cause Bursal Lesions”,Journal of Virology, Apr. 1998 p. 2647-2654.
Lütticken Heinrich Dieter
Mundt Egbert
van Loon Adriaan Anthonius Wilhelmus Maria
Akzo Nobel N.V.
Blackstone William M.
Foley Shanon
Gormley Mary
Ramey III William P.
LandOfFree
Recombinant birnavirus vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant birnavirus vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant birnavirus vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3559460